西班牙临床药理学学会第三十二届大会,2024 年 10 月 16-18 日,西班牙圣地亚哥德孔波斯特拉。

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
{"title":"西班牙临床药理学学会第三十二届大会,2024 年 10 月 16-18 日,西班牙圣地亚哥德孔波斯特拉。","authors":"","doi":"10.1111/bcpt.14065","DOIUrl":null,"url":null,"abstract":"<p><b>WEDNESDAY 16 OCTOBER 2024</b></p><p>10:00–14:00<b>    ANNUAL MEETING OF RESEARCH ETHICS COMMITTEES</b></p><p>Spanish Agency of Medicines and Medical Devices and Spanish Society of Clinical Pharmacology</p><p>15:30–18:30<b>    PRE-CONGRESS WORKSHOPS AND SEMINARS</b></p><p><b>“Next-generation of “deep” medicine: A look from machine learning to generative AI”</b></p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>Laura Romero Sánchez. <i>Technical Secretary of Research Ethics Committee of Galicia</i>, <i>Gerencia del Servicio Gallego de Salud</i>.</p><p><b>“Drafting and requesting competitive projects”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Paula López Vázquez. <i>Clinical Pharmacologist, Dirección Xeral de Asistencia Sanitaria-Servizo Galego de Saúde</i>.</p><p><b>“Professional opportunities for the specialty of clinical pharmacology”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p><b>“Evaluation of the therapeutic value of medicines: controversies and future perspectives”</b></p><p>Arantxa Sancho López. <i>Clinical Pharmacologist, Head of Medical-Scientific Department of Farmaindustria</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Pedro Zapater Hernández<i>. Head of Section of Clinical Pharmacology Department, Hospital General Universitario Dr. Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>Alejandro García Solís. <i>Therapeutic Positioning Reporting Area and Health Technology Assessment, Spanish Agency of Medicines and Medical Devices</i>.</p><p><b>“Medicines in special situations”</b></p><p>Concepción Payares Herrera. <i>Clinical Pharmacologist, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Imma Danés Carreras. <i>Head of section of Clinical Pharmacology Department, Hospital Universitario Vall d'Hebron, Barcelona</i>.</p><p>19:00      <b>INAUGURATION OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p><p>19:30<b>      INAUGURAL CONFERENCE</b></p><p><b>“Novelties in therapeutics: Advanced therapies and other innovations”</b></p><p>Cristina Avendaño Solá. Head of Clinical Pharmacology Department, Hospital Puerta de Hierro, Majadahonda, Universidad Autónoma, Madrid.</p><p>20:30<b>      WELCOME COCKTAIL</b></p><p><b>THURSDAY 17 OCTOBER 2024</b></p><p>08:30–09:15<b>    REGISTRATION</b></p><p>09:15–11:15    <b>1ST ROUND TABLE</b></p><p><b>“Medicine research in Europe, pros and cons of making the medicine authorization process more flexible”</b></p><p>Moderators:</p><p>Ana Lucía Arellano Andrino. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>09:20–09:40    <b>“Evolution of medicine authorization procedures in Europe”</b></p><p>Macarena Rodríguez Mendizábal. <i>Division of Clinical Pharmacology and Assessment of Medicines, Spanish Agency of Medicines and Clinical Devices</i>.</p><p>09:40–10:00    <b>“Impact of accelerating medicine authorization processes on healthcare management”</b></p><p>Antoni Vallano Ferraz. <i>Coordinator of the Drug Harmonization Program, Àrea del Medicament del Servei Català de la Salut</i>.</p><p>10:00–10:20    <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the paediatric population”</b></p><p>Federico Martinón Torres. <i>Head of Paediatric Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:20–10:40    <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the oncological patients”</b></p><p>Luis León Mateos. <i>Head of Section of Research and Innovation, Clinical Oncology Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:40–11:15    <b>DISCUSSION</b></p><p>11:15–12:00    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>12:00–13:30    <b>1ST SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>Encarnación Blanco Reina. <i>Clinical Pharmacologist, Department of Pharmacology and Paediatrics, Universidad de Málaga</i>.</p><p>Pedro Zapater Hernández. <i>Head of Section Clinical Pharmacology Department, Hospital General Universitario Dr Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>13:30–14:00    <b>“Strategy for the implementation of pharmacogenetics at the healthcare level in the Community of Madrid”</b></p><p>Susana Almenara Riquer. <i>Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid</i>.</p><p>Elena Diago Sempere. <i>Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid</i>.</p><p>Gustavo Centeno Soto. <i>Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Ana Ascaso del Río. <i>Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid</i>.</p><p>Antonio Carcas Sansúan<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Alberto Borobia Pérez<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Cristina Avendaño Sola. <i>Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Francisco Abad Santos. <i>Hospital Universitario de la Princesa, Madrid</i>.</p><p>14:00–15:30    <b>LUNCH</b></p><p>15:30–17:00    <b>2ND ROUND TABLE</b></p><p><b>“Chronic diseases, polytherapy and health outcomes”</b></p><p>Moderators:</p><p>Mª Estrella Barceló Colomer. <i>Clinical Pharmacologist, Medicine Area of Primary Care Management and Community Care in Barcelona City, Institut Català de la Salut</i>.</p><p>Mario González Ruíz. <i>Clinical Pharmacologist, Clinical Pharmacology Department of Primary Care, Gerencia de Atención Primaria del Servicio Cántabro de Salud</i>.</p><p>15:35–15:55    <b>“The epidemiology of chronicity and polypharmacy”</b></p><p>Arturo González Quintela. <i>Specialist in Internal Medicine, Head of Section Internal Medicine Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>15:55–16:15    <b>“Polypharmacy and deprescription”</b></p><p>Beatriz Montero Errasquín. <i>Specialist in Geriatrics, Head of Section Geriatric Department, Hospital Universitario Ramón y Cajal, Servicio Madrileño de Salud</i>.</p><p>16:15–16:35    <b>“Health outcomes in chronic patients with polytherapy”</b></p><p>Rosendo Bugarín González. <i>Family Doctor, Monforte de Lemos Health Center, Servicio Galego de Saúde</i>.</p><p>16:35–17:00    <b>DISCUSSION</b></p><p>17:00–17:30    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>17:30–19:30    <b>GENERAL ASSEMBLY OF THE SPANISH SOCIETY OF CLINICAL PHARMACOLOGY</b></p><p>21:00      <b>CONGRESS DINNER</b></p><p><b>FRIDAY 18 OCTOBER 2024</b></p><p>09:00–10:30    <b>2ND SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>María del Mar García Saiz. <i>Head of Clinical Pharmacology Department, Hospital Universitario Marqués de Valdecilla, Santander</i>.</p><p>Amelia García Luque. <i>Head of Clinical Pharmacology Department, Hospital Central de la Defensa, Madrid</i>.</p><p>10:30–11:00    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>11:00–13:00    <b>3RD ROUND TABLE</b></p><p><b>“Artificial intelligence in Medicine: technology, research, education and ethics”</b></p><p>Moderators:</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>11:05–11:25    <b>“Generative AI in Medicine”</b></p><p>Senén Barro Ameneiro. <i>Director of the USC-Plexus of AI in personalized precision medicine and director of the unique research center in intelligent technologies, Universidad de Santiago de Compostela</i>.</p><p>11:25–11:45    <b>“Use of artificial intelligence in pharmacoepidemiological research: Experience and application perspectives in BIFAP”</b></p><p>Miguel Ángel Maciá Martínez. <i>Coordinator of the Pharmacoepidemiologic Research in Public Health Systems Database, Head of the Pharmacoepidemiology Area, Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices</i>.</p><p>11:45–12:05    <b>“Challenges for the widespread implementation of AI in healthcare”</b></p><p>Maria José Carreira Nouche. <i>Unique Research Center in Intelligent Technologies, Universidad de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela</i>.</p><p>12:05–12:25    <b>“Reliable AI in Medicine: Regulation and Ethics”</b></p><p>Juan Díaz García. <i>Specialist in Preventive Medicine and Public Health Data, Protection Officer of the Public Health System of Andalusia, Member of the Andalusian Biomedical Research Ethics Coordinating Committee</i>.</p><p>12:25–13:00    <b>DISCUSSION</b></p><p>13:00–13:30    <b>CLOSING CONFERENCE</b></p><p><b>“The evidence needed to approve medicines: are we witnessing a paradigm shift?”</b></p><p>Fernando de Andrés Trelles. <i>Emeritus Professor, Department of Pharmacology and Toxicology, Universidad Complutense, Madrid</i>.</p><p>13:30–14:00    <b>AWARDS AND CLOSURE CEREMONY</b></p><p>Prize for the best research work (best communication).</p><p>Sponsored by Chiesi Spain.</p><p>Prize for the best publication in a scientific journal.</p><p>Sponsored by Lilly.</p><p><b>CLOSURE OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"135 S1","pages":"5-8"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.14065","citationCount":"0","resultStr":"{\"title\":\"Scientific program\",\"authors\":\"\",\"doi\":\"10.1111/bcpt.14065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>WEDNESDAY 16 OCTOBER 2024</b></p><p>10:00–14:00<b>    ANNUAL MEETING OF RESEARCH ETHICS COMMITTEES</b></p><p>Spanish Agency of Medicines and Medical Devices and Spanish Society of Clinical Pharmacology</p><p>15:30–18:30<b>    PRE-CONGRESS WORKSHOPS AND SEMINARS</b></p><p><b>“Next-generation of “deep” medicine: A look from machine learning to generative AI”</b></p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>Laura Romero Sánchez. <i>Technical Secretary of Research Ethics Committee of Galicia</i>, <i>Gerencia del Servicio Gallego de Salud</i>.</p><p><b>“Drafting and requesting competitive projects”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Paula López Vázquez. <i>Clinical Pharmacologist, Dirección Xeral de Asistencia Sanitaria-Servizo Galego de Saúde</i>.</p><p><b>“Professional opportunities for the specialty of clinical pharmacology”</b></p><p>Joaquín Sáez Peñataro. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p><b>“Evaluation of the therapeutic value of medicines: controversies and future perspectives”</b></p><p>Arantxa Sancho López. <i>Clinical Pharmacologist, Head of Medical-Scientific Department of Farmaindustria</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Pedro Zapater Hernández<i>. Head of Section of Clinical Pharmacology Department, Hospital General Universitario Dr. Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>Alejandro García Solís. <i>Therapeutic Positioning Reporting Area and Health Technology Assessment, Spanish Agency of Medicines and Medical Devices</i>.</p><p><b>“Medicines in special situations”</b></p><p>Concepción Payares Herrera. <i>Clinical Pharmacologist, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Imma Danés Carreras. <i>Head of section of Clinical Pharmacology Department, Hospital Universitario Vall d'Hebron, Barcelona</i>.</p><p>19:00      <b>INAUGURATION OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p><p>19:30<b>      INAUGURAL CONFERENCE</b></p><p><b>“Novelties in therapeutics: Advanced therapies and other innovations”</b></p><p>Cristina Avendaño Solá. Head of Clinical Pharmacology Department, Hospital Puerta de Hierro, Majadahonda, Universidad Autónoma, Madrid.</p><p>20:30<b>      WELCOME COCKTAIL</b></p><p><b>THURSDAY 17 OCTOBER 2024</b></p><p>08:30–09:15<b>    REGISTRATION</b></p><p>09:15–11:15    <b>1ST ROUND TABLE</b></p><p><b>“Medicine research in Europe, pros and cons of making the medicine authorization process more flexible”</b></p><p>Moderators:</p><p>Ana Lucía Arellano Andrino. <i>Clinical Pharmacologist, Hospital Clínic, Barcelona</i>.</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>09:20–09:40    <b>“Evolution of medicine authorization procedures in Europe”</b></p><p>Macarena Rodríguez Mendizábal. <i>Division of Clinical Pharmacology and Assessment of Medicines, Spanish Agency of Medicines and Clinical Devices</i>.</p><p>09:40–10:00    <b>“Impact of accelerating medicine authorization processes on healthcare management”</b></p><p>Antoni Vallano Ferraz. <i>Coordinator of the Drug Harmonization Program, Àrea del Medicament del Servei Català de la Salut</i>.</p><p>10:00–10:20    <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the paediatric population”</b></p><p>Federico Martinón Torres. <i>Head of Paediatric Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:20–10:40    <b>“The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the oncological patients”</b></p><p>Luis León Mateos. <i>Head of Section of Research and Innovation, Clinical Oncology Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>10:40–11:15    <b>DISCUSSION</b></p><p>11:15–12:00    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>12:00–13:30    <b>1ST SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>Encarnación Blanco Reina. <i>Clinical Pharmacologist, Department of Pharmacology and Paediatrics, Universidad de Málaga</i>.</p><p>Pedro Zapater Hernández. <i>Head of Section Clinical Pharmacology Department, Hospital General Universitario Dr Balmis, Universidad Miguel Hernández, Alicante</i>.</p><p>13:30–14:00    <b>“Strategy for the implementation of pharmacogenetics at the healthcare level in the Community of Madrid”</b></p><p>Susana Almenara Riquer. <i>Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid</i>.</p><p>Elena Diago Sempere. <i>Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid</i>.</p><p>Gustavo Centeno Soto. <i>Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Ana Ascaso del Río. <i>Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid</i>.</p><p>Antonio Carcas Sansúan<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Alberto Borobia Pérez<i>. Hospital Universitario La Paz, Madrid</i>.</p><p>Cristina Avendaño Sola. <i>Hospital Universitario Puerta de Hierro, Majadahonda, Madrid</i>.</p><p>Francisco Abad Santos. <i>Hospital Universitario de la Princesa, Madrid</i>.</p><p>14:00–15:30    <b>LUNCH</b></p><p>15:30–17:00    <b>2ND ROUND TABLE</b></p><p><b>“Chronic diseases, polytherapy and health outcomes”</b></p><p>Moderators:</p><p>Mª Estrella Barceló Colomer. <i>Clinical Pharmacologist, Medicine Area of Primary Care Management and Community Care in Barcelona City, Institut Català de la Salut</i>.</p><p>Mario González Ruíz. <i>Clinical Pharmacologist, Clinical Pharmacology Department of Primary Care, Gerencia de Atención Primaria del Servicio Cántabro de Salud</i>.</p><p>15:35–15:55    <b>“The epidemiology of chronicity and polypharmacy”</b></p><p>Arturo González Quintela. <i>Specialist in Internal Medicine, Head of Section Internal Medicine Department, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>15:55–16:15    <b>“Polypharmacy and deprescription”</b></p><p>Beatriz Montero Errasquín. <i>Specialist in Geriatrics, Head of Section Geriatric Department, Hospital Universitario Ramón y Cajal, Servicio Madrileño de Salud</i>.</p><p>16:15–16:35    <b>“Health outcomes in chronic patients with polytherapy”</b></p><p>Rosendo Bugarín González. <i>Family Doctor, Monforte de Lemos Health Center, Servicio Galego de Saúde</i>.</p><p>16:35–17:00    <b>DISCUSSION</b></p><p>17:00–17:30    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>17:30–19:30    <b>GENERAL ASSEMBLY OF THE SPANISH SOCIETY OF CLINICAL PHARMACOLOGY</b></p><p>21:00      <b>CONGRESS DINNER</b></p><p><b>FRIDAY 18 OCTOBER 2024</b></p><p>09:00–10:30    <b>2ND SESSION OF ORAL COMMUNICATIONS</b></p><p>Moderators:</p><p>María del Mar García Saiz. <i>Head of Clinical Pharmacology Department, Hospital Universitario Marqués de Valdecilla, Santander</i>.</p><p>Amelia García Luque. <i>Head of Clinical Pharmacology Department, Hospital Central de la Defensa, Madrid</i>.</p><p>10:30–11:00    <b>COFFEE BREAK, POSTER SESSION AND NETWORKING</b></p><p>11:00–13:00    <b>3RD ROUND TABLE</b></p><p><b>“Artificial intelligence in Medicine: technology, research, education and ethics”</b></p><p>Moderators:</p><p>Emilio Vargas Castrillón. <i>Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid</i>.</p><p>Guillermo Prada Ramallal. <i>Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela</i>.</p><p>11:05–11:25    <b>“Generative AI in Medicine”</b></p><p>Senén Barro Ameneiro. <i>Director of the USC-Plexus of AI in personalized precision medicine and director of the unique research center in intelligent technologies, Universidad de Santiago de Compostela</i>.</p><p>11:25–11:45    <b>“Use of artificial intelligence in pharmacoepidemiological research: Experience and application perspectives in BIFAP”</b></p><p>Miguel Ángel Maciá Martínez. <i>Coordinator of the Pharmacoepidemiologic Research in Public Health Systems Database, Head of the Pharmacoepidemiology Area, Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices</i>.</p><p>11:45–12:05    <b>“Challenges for the widespread implementation of AI in healthcare”</b></p><p>Maria José Carreira Nouche. <i>Unique Research Center in Intelligent Technologies, Universidad de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela</i>.</p><p>12:05–12:25    <b>“Reliable AI in Medicine: Regulation and Ethics”</b></p><p>Juan Díaz García. <i>Specialist in Preventive Medicine and Public Health Data, Protection Officer of the Public Health System of Andalusia, Member of the Andalusian Biomedical Research Ethics Coordinating Committee</i>.</p><p>12:25–13:00    <b>DISCUSSION</b></p><p>13:00–13:30    <b>CLOSING CONFERENCE</b></p><p><b>“The evidence needed to approve medicines: are we witnessing a paradigm shift?”</b></p><p>Fernando de Andrés Trelles. <i>Emeritus Professor, Department of Pharmacology and Toxicology, Universidad Complutense, Madrid</i>.</p><p>13:30–14:00    <b>AWARDS AND CLOSURE CEREMONY</b></p><p>Prize for the best research work (best communication).</p><p>Sponsored by Chiesi Spain.</p><p>Prize for the best publication in a scientific journal.</p><p>Sponsored by Lilly.</p><p><b>CLOSURE OF THE CONGRESS</b></p><p>Antònia Agustí Escasany. <i>President of the Spanish Society of Clinical Pharmacology</i>.</p><p>Emilio Vargas Castrillón. <i>President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Guillermo Prada Ramallal<i>. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology</i>.</p><p>Carmen Durán. <i>General Director of Public Health, Consejería de Sanidad Gobierno Gallego</i>.</p>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\"135 S1\",\"pages\":\"5-8\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.14065\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14065\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14065","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

安东尼奥-卡尔卡斯-桑苏安马德里拉巴斯大学医院.Alberto Borobia Pérez.马德里拉巴斯大学医院.Cristina Avendaño Sola.马德里马亚达洪达 Puerta de Hierro 大学医院.Francisco Abad Santos.14:00-15:30 午餐15:30-17:00 第二场圆桌会议 "慢性病、多种疗法和健康结果 "主持人:Mª Estrella Barceló Colomer.加泰罗尼亚健康研究所巴塞罗那市初级医疗管理和社区医疗医学领域临床药理学家。Gerencia de Atención Primaria del Servicio Cántabro de Salud 初级医疗临床药理学部临床药理学家。15:35-15:55 "慢性病和多重用药的流行病学 "Arturo González Quintela.内科专家,圣地亚哥-德孔波斯特拉大学医院内科主任。15:55-16:15 "多重用药和停药 "比阿特丽斯-蒙特罗-埃拉斯金。16:15-16:35 "多药治疗慢性病患者的健康状况 "Rosendo Bugarín González.家庭医生,Monforte de Lemos 健康中心,Servicio Galego de Saúde.16:35-17:00:35-17:00 讨论17:00-17:30 茶歇、海报展和网络交流17:30-19:30 西班牙临床药理学会大会21:00 大会晚宴202 年 10 月 18 日星期四9:00-10:30 第二场口头交流主持:玛丽亚-德尔-玛-加西亚-赛伊斯。桑坦德 Marqués de Valdecilla 大学医院临床药理学部主任。10:30-11:00 茶歇、海报展和网络交流11:00-13:00 第三圆桌会议 "人工智能在医学中的应用:技术、研究、教育和伦理 "主持人:埃米利奥-巴尔加斯-卡斯特里隆(Emilio Vargas Castrillón)。马德里康普斯顿大学圣卡洛斯医院临床药理学系主任、药理学教授。11:05-11:25 "生成式人工智能在医学中的应用 "Senén Barro Ameneiro.11:25-11:45 "人工智能在药物流行病学研究中的应用:米格尔-安赫尔-马西亚-马丁内斯(Miguel Ángel Maciá Martínez)。公共卫生系统数据库药物流行病学研究协调员,西班牙药品和医疗器械管理局药物流行病学和药物警戒司药物流行病学领域负责人。11:45-12:05 "在医疗保健领域广泛应用人工智能的挑战 "Maria José Carreira Nouche.圣地亚哥-德孔波斯特拉大学智能技术独特研究中心,圣地亚哥-德孔波斯特拉卫生研究所基金会:监管与伦理 "胡安-迪亚斯-加西亚。预防医学和公共卫生数据专家,安达卢西亚公共卫生系统保护官员,安达卢西亚生物医学研究伦理协调委员会成员。12:25-13:00 讨论13:00-13:30 闭幕会议 "批准药品所需的证据:我们是否正在见证范式的转变?"费尔南多-德安德烈斯-特雷利斯。马德里康普斯顿大学药理学和毒理学系名誉教授。13:30-14:00 颁奖和闭幕式最佳研究工作奖(最佳交流奖),由西班牙 Chiesi 公司赞助。最佳科学期刊论文奖,由礼来公司赞助。西班牙临床药理学会主席。西班牙临床药理学会第三十二届大会组委会主席。西班牙临床药理学会第三十二届大会科学委员会主席。加列戈政府卫生委员会公共卫生总监。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Scientific program

WEDNESDAY 16 OCTOBER 2024

10:00–14:00    ANNUAL MEETING OF RESEARCH ETHICS COMMITTEES

Spanish Agency of Medicines and Medical Devices and Spanish Society of Clinical Pharmacology

15:30–18:30    PRE-CONGRESS WORKSHOPS AND SEMINARS

“Next-generation of “deep” medicine: A look from machine learning to generative AI”

Guillermo Prada Ramallal. Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela.

Laura Romero Sánchez. Technical Secretary of Research Ethics Committee of Galicia, Gerencia del Servicio Gallego de Salud.

“Drafting and requesting competitive projects”

Joaquín Sáez Peñataro. Clinical Pharmacologist, Hospital Clínic, Barcelona.

Paula López Vázquez. Clinical Pharmacologist, Dirección Xeral de Asistencia Sanitaria-Servizo Galego de Saúde.

“Professional opportunities for the specialty of clinical pharmacology”

Joaquín Sáez Peñataro. Clinical Pharmacologist, Hospital Clínic, Barcelona.

“Evaluation of the therapeutic value of medicines: controversies and future perspectives”

Arantxa Sancho López. Clinical Pharmacologist, Head of Medical-Scientific Department of Farmaindustria.

Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.

Pedro Zapater Hernández. Head of Section of Clinical Pharmacology Department, Hospital General Universitario Dr. Balmis, Universidad Miguel Hernández, Alicante.

Alejandro García Solís. Therapeutic Positioning Reporting Area and Health Technology Assessment, Spanish Agency of Medicines and Medical Devices.

“Medicines in special situations”

Concepción Payares Herrera. Clinical Pharmacologist, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid.

Imma Danés Carreras. Head of section of Clinical Pharmacology Department, Hospital Universitario Vall d'Hebron, Barcelona.

19:00      INAUGURATION OF THE CONGRESS

Antònia Agustí Escasany. President of the Spanish Society of Clinical Pharmacology.

Emilio Vargas Castrillón. President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.

Guillermo Prada Ramallal. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.

Carmen Durán. General Director of Public Health, Consejería de Sanidad Gobierno Gallego.

19:30      INAUGURAL CONFERENCE

“Novelties in therapeutics: Advanced therapies and other innovations”

Cristina Avendaño Solá. Head of Clinical Pharmacology Department, Hospital Puerta de Hierro, Majadahonda, Universidad Autónoma, Madrid.

20:30      WELCOME COCKTAIL

THURSDAY 17 OCTOBER 2024

08:30–09:15    REGISTRATION

09:15–11:15    1ST ROUND TABLE

“Medicine research in Europe, pros and cons of making the medicine authorization process more flexible”

Moderators:

Ana Lucía Arellano Andrino. Clinical Pharmacologist, Hospital Clínic, Barcelona.

Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.

09:20–09:40    “Evolution of medicine authorization procedures in Europe”

Macarena Rodríguez Mendizábal. Division of Clinical Pharmacology and Assessment of Medicines, Spanish Agency of Medicines and Clinical Devices.

09:40–10:00    “Impact of accelerating medicine authorization processes on healthcare management”

Antoni Vallano Ferraz. Coordinator of the Drug Harmonization Program, Àrea del Medicament del Servei Català de la Salut.

10:00–10:20    “The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the paediatric population”

Federico Martinón Torres. Head of Paediatric Department, Hospital Clínico Universitario, Santiago de Compostela.

10:20–10:40    “The research on medicines in Europe, pros and cons of making the drug authorization more flexible. Advantages and uncertainties in the oncological patients”

Luis León Mateos. Head of Section of Research and Innovation, Clinical Oncology Department, Hospital Clínico Universitario, Santiago de Compostela.

10:40–11:15    DISCUSSION

11:15–12:00    COFFEE BREAK, POSTER SESSION AND NETWORKING

12:00–13:30    1ST SESSION OF ORAL COMMUNICATIONS

Moderators:

Encarnación Blanco Reina. Clinical Pharmacologist, Department of Pharmacology and Paediatrics, Universidad de Málaga.

Pedro Zapater Hernández. Head of Section Clinical Pharmacology Department, Hospital General Universitario Dr Balmis, Universidad Miguel Hernández, Alicante.

13:30–14:00    “Strategy for the implementation of pharmacogenetics at the healthcare level in the Community of Madrid”

Susana Almenara Riquer. Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid.

Elena Diago Sempere. Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid.

Gustavo Centeno Soto. Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid.

Ana Ascaso del Río. Clinical Pharmacology Department, Hospital Universitario Clínico San Carlos, Madrid.

Antonio Carcas Sansúan. Hospital Universitario La Paz, Madrid.

Alberto Borobia Pérez. Hospital Universitario La Paz, Madrid.

Cristina Avendaño Sola. Hospital Universitario Puerta de Hierro, Majadahonda, Madrid.

Francisco Abad Santos. Hospital Universitario de la Princesa, Madrid.

14:00–15:30    LUNCH

15:30–17:00    2ND ROUND TABLE

“Chronic diseases, polytherapy and health outcomes”

Moderators:

Mª Estrella Barceló Colomer. Clinical Pharmacologist, Medicine Area of Primary Care Management and Community Care in Barcelona City, Institut Català de la Salut.

Mario González Ruíz. Clinical Pharmacologist, Clinical Pharmacology Department of Primary Care, Gerencia de Atención Primaria del Servicio Cántabro de Salud.

15:35–15:55    “The epidemiology of chronicity and polypharmacy”

Arturo González Quintela. Specialist in Internal Medicine, Head of Section Internal Medicine Department, Hospital Clínico Universitario, Santiago de Compostela.

15:55–16:15    “Polypharmacy and deprescription”

Beatriz Montero Errasquín. Specialist in Geriatrics, Head of Section Geriatric Department, Hospital Universitario Ramón y Cajal, Servicio Madrileño de Salud.

16:15–16:35    “Health outcomes in chronic patients with polytherapy”

Rosendo Bugarín González. Family Doctor, Monforte de Lemos Health Center, Servicio Galego de Saúde.

16:35–17:00    DISCUSSION

17:00–17:30    COFFEE BREAK, POSTER SESSION AND NETWORKING

17:30–19:30    GENERAL ASSEMBLY OF THE SPANISH SOCIETY OF CLINICAL PHARMACOLOGY

21:00      CONGRESS DINNER

FRIDAY 18 OCTOBER 2024

09:00–10:30    2ND SESSION OF ORAL COMMUNICATIONS

Moderators:

María del Mar García Saiz. Head of Clinical Pharmacology Department, Hospital Universitario Marqués de Valdecilla, Santander.

Amelia García Luque. Head of Clinical Pharmacology Department, Hospital Central de la Defensa, Madrid.

10:30–11:00    COFFEE BREAK, POSTER SESSION AND NETWORKING

11:00–13:00    3RD ROUND TABLE

“Artificial intelligence in Medicine: technology, research, education and ethics”

Moderators:

Emilio Vargas Castrillón. Professor of Pharmacology, Head of Clinical Pharmacology Department, Hospital Clínico San Carlos, Universidad Complutense, Madrid.

Guillermo Prada Ramallal. Clinical Pharmacologist, Hospital Clínico Universitario, Santiago de Compostela.

11:05–11:25    “Generative AI in Medicine”

Senén Barro Ameneiro. Director of the USC-Plexus of AI in personalized precision medicine and director of the unique research center in intelligent technologies, Universidad de Santiago de Compostela.

11:25–11:45    “Use of artificial intelligence in pharmacoepidemiological research: Experience and application perspectives in BIFAP”

Miguel Ángel Maciá Martínez. Coordinator of the Pharmacoepidemiologic Research in Public Health Systems Database, Head of the Pharmacoepidemiology Area, Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices.

11:45–12:05    “Challenges for the widespread implementation of AI in healthcare”

Maria José Carreira Nouche. Unique Research Center in Intelligent Technologies, Universidad de Santiago de Compostela, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela.

12:05–12:25    “Reliable AI in Medicine: Regulation and Ethics”

Juan Díaz García. Specialist in Preventive Medicine and Public Health Data, Protection Officer of the Public Health System of Andalusia, Member of the Andalusian Biomedical Research Ethics Coordinating Committee.

12:25–13:00    DISCUSSION

13:00–13:30    CLOSING CONFERENCE

“The evidence needed to approve medicines: are we witnessing a paradigm shift?”

Fernando de Andrés Trelles. Emeritus Professor, Department of Pharmacology and Toxicology, Universidad Complutense, Madrid.

13:30–14:00    AWARDS AND CLOSURE CEREMONY

Prize for the best research work (best communication).

Sponsored by Chiesi Spain.

Prize for the best publication in a scientific journal.

Sponsored by Lilly.

CLOSURE OF THE CONGRESS

Antònia Agustí Escasany. President of the Spanish Society of Clinical Pharmacology.

Emilio Vargas Castrillón. President of the Organizing Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.

Guillermo Prada Ramallal. President of the Scientific Committee of the XXXII Congress of the Spanish Society of Clinical Pharmacology.

Carmen Durán. General Director of Public Health, Consejería de Sanidad Gobierno Gallego.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信